Scholars Central

Review articlePublished 2015

Biomarkers of Response to Immune Modulatory Therapies in Cancer

Authors: Andrew JS Furness, Kroopa Joshi, Karl S Peggs, Sergio A Quezada

Journal of Clinical and Cellular Immunology

Volume 6 · Issue 4 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Immune modulatory antibody-based therapies serve to augment and direct the endogenous immune response against cancer. Significant efficacy has been demonstrated in multiple subtypes of solid and haematological malignancies. Despite great promise, responses are limited to a fraction of treated patients highlighting the need to decipher underlying mechanisms of response and resistance. Here we review progress in this area with a focus on the identification of candidate predictive biomarkers of response.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Andrew JS Furness”
  • BylineArticles whose byline prints “Kroopa Joshi”
  • BylineArticles whose byline prints “Karl S Peggs”
  • BylineArticles whose byline prints “Sergio A Quezada”